Predictive Values of Serotonergic Alterations for Outcome - 2

NCT00000313 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Fenfluramine

Sponsors & Collaborators

  • VA Office of Research and Development

    collaborator FED
  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Laure Buydens-Branchey, M.D. · VA Medical Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000313 on ClinicalTrials.gov